The Valley Desk

NCT05650749 · Interventional trial

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

Overall registry status Enrolling by invitation

Phase 1

Conditions High-risk Neuroblastoma, Metastatic Retinoblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma, Retinoblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov